To evaluate the degrees of anxiety and depression among type 2 diabetic mellitus patients who are seeking dental treatment. Method: In a preliminary investigation, 20 individuals diagnosed with type 2 diabetes mellitus who presented for dental treatment underwent assessment using the Hospital Anxiety and Depression Scale (HADS) to measure anxiety levels. The HADS questionnaire analyses anxiety and depression based on a predefined set of 14 items. Results from the HADS scoring categorize patients into normal, borderline abnormal, and abnormal anxiety levels. Results: The average anxiety score among participants with diabetes mellitus was 11.4, while the depression score was 12. Elevated anxiety and depression scores were notably observed among female participants, older individuals, those with a longer duration of diabetes, and patients with both diabetes and other health conditions. The original English version of the HADS scale was translated into the local regional language for this study. Conclusion: Depression and anxiety rates are notably elevated among diabetic patients seeking dental care. The presence of diabetes often compromises quality of life, emphasizing the critical need for timely diagnosis and effective management of anxiety and depression in individuals with type 2 diabetes mellitus to enhance overall well-being.